Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | Any - 11 |
| Updated: | 4/27/2017 |
| Start Date: | June 2013 |
| End Date: | August 2017 |
Safety and Efficacy of Topical Loteprednol Etabonate 0.5%, Versus Prednisolone Acetate 1%, for the Treatment of Intraocular Inflammation Following Surgery for Childhood Cataract
The objective of this study is to compare the efficacy and safety for the treatment of
postoperative inflammation following ocular surgery for childhood cataract.
postoperative inflammation following ocular surgery for childhood cataract.
The objective of this study is to compare the efficacy and safety of topical Loteprednol
Etabonate (LE), 0.5%, to Prednisolone Acetate 1%, for the treatment of postoperative
inflammation following ocular surgery for childhood cataract.
Etabonate (LE), 0.5%, to Prednisolone Acetate 1%, for the treatment of postoperative
inflammation following ocular surgery for childhood cataract.
Inclusion Criteria:
- Subject is a candidate for routine, uncomplicated surgery for childhood cataract
Exclusion Criteria:
- Subjects who have a severe/serious ocular condition, or any other unstable medical
condition that, in the Investigator's opinion, may preclude study treatment or
follow-up.
- Subjects with glaucoma, ocular hypertension, or those receiving intraocular pressure
(IOP) lowering therapy in either eye or systemically.
- Subjects with a history of steroid-induced IOP elevation in either eye.
- Subjects who have known hypersensitivity or other contraindication to the study
drug(s) or any components in the drug formulation.
We found this trial at
1
site
Click here to add this to my saved trials
